pdf-articles Ratings /ratings/en/research/pdf-articles/210217-emerging-markets-monthly-highlights-despite-vaccines-normality-still-elusive-100049029 content esgSubNav

Emerging Markets Monthly Highlights: Despite Vaccines, Normality Still Elusive

February 17, 2021

There are signs that economic conditions across most emerging markets (EMs) have improved marginally, following an overall setback in activity in late December early January. COVID-19 cases started to decline at the end of January, which coincided with an improvement in mobility-related indicators. Manufacturing confidence indices remain near their recent highs, and so do commodity prices, suggesting the goods-driven recovery remained broadly in place in January. However, downside risks to growth are still considerable, given the fluid pandemic-related developments and varying degrees of lockdowns in most EMs.


Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back